OGN OGN
Company Profile ↓Company Overview
OGN (OGN) is a publicly traded company listed on with a market capitalization of $3.53B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 24.9%, reflecting efficient use of shareholder capital.
Operating margin of 19.7% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $6.22B (-2.9% YoY); net profit $187.00M.
- Trailing 12 Months Year-on-year growth — revenue -2.9%, earnings -78.4%.
- 5-Year Trend Long-term compounding — revenue CAGR -4.4%, profit CAGR -43.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -4.38% |
| 1 Year: | -2.92% |
Compounded Profit Growth
| 5 Years: | -43.40% |
| 1 Year: | -78.36% |
Stock Price Performance
| 1 Year: | +41.57% |
| 6 Months: | +70.30% |
| 3 Months: | +1.80% |
| 1 Month: | +0.44% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)64.77 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 24.9%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -4.4% CAGR over 5 years.
- Earnings shrank at -43.4% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.78B | 1.53B | 1.61B | 1.51B | 1.59B | 1.60B | 1.57B | 1.58B | 1.54B | 1.54B | 1.61B | 1.52B | 1.62B | 1.61B | 1.58B | - | - | 1.59B | 1.60B | 1.51B | 1.46B | 1.56B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 720.00M | 745.00M | 766.00M | 677.00M | 711.00M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | 968.00M | 907.00M | 957.00M | 939.00M | 923.00M | - | - | 874.00M | 857.00M | 741.00M | 783.00M | 847.00M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 548.00M | 499.00M | 524.00M | 517.00M | 524.00M |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 326.00M | 358.00M | 217.00M | 266.00M | 323.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 449.00M | 463.00M | 69.00M | 410.00M | 371.00M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 131.00M | 128.00M | 121.00M | 111.00M | 108.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 229.00M | 243.00M | -148.00M | 213.00M | 183.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 84.00M | 83.00M | 57.00M | 67.00M | 75.00M |
| Net Income | 703.00M | 542.00M | 547.00M | 399.00M | 427.00M | 323.00M | 348.00M | 234.00M | 227.00M | 177.00M | 242.00M | 58.00M | 201.00M | 195.00M | 359.00M | - | - | 145.00M | 160.00M | -205.00M | 146.00M | 108.00M |
| Diluted EPS | 2.78 | 2.14 | 2.16 | 1.58 | 1.68 | 1.27 | 1.36 | 0.92 | 0.89 | 0.69 | 0.95 | 0.23 | 0.78 | 0.75 | 1.38 | - | - | 0.56 | 0.61 | -0.79 | 0.55 | 0.40 |
| R&D Expense | 45.00M | 51.00M | 54.00M | 67.00M | 76.00M | 111.00M | 96.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 7.78B | 6.53B | - | 6.17B | 6.26B | 6.40B | 6.22B |
| Cost of Revenue | - | - | - | 2.29B | 2.52B | 2.69B | 2.90B |
| Gross Profit | - | - | - | 3.88B | 3.75B | 3.71B | 3.31B |
| Operating Expenses | - | - | - | 2.17B | 2.42B | 2.23B | 2.09B |
| Operating Income | - | - | - | 1.71B | 1.33B | 1.49B | 1.23B |
| EBITDA | - | - | - | 1.76B | 1.44B | 1.60B | 1.29B |
| Interest Expense | - | - | - | 422.00M | 527.00M | 520.00M | 504.00M |
| Pretax Income | - | - | - | 1.12B | 673.00M | 807.00M | 425.00M |
| Tax Provision | - | - | - | 205.00M | -350.00M | -57.00M | 238.00M |
| Net Income | 3.22B | 2.16B | - | 917.00M | 1.02B | 864.00M | 187.00M |
| Diluted EPS | 12.69 | 8.52 | - | 3.59 | 3.99 | 3.33 | 0.72 |
| R&D Expense | 220.00M | 210.00M | 443.00M | - | - | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 10.11B | - | 10.96B | 12.06B | 13.10B | 12.87B |
| Current Assets | - | - | - | - | 3.93B | 4.51B | 4.35B | 4.35B |
| Cash & Equivalents | - | - | 12.00M | - | 706.00M | 693.00M | 675.00M | 574.00M |
| Inventory | - | - | - | - | 1.00B | 1.31B | 1.32B | 1.41B |
| Receivables | - | - | - | - | 1.48B | 1.74B | 1.36B | 1.33B |
| Total Liabilities | - | - | - | - | 11.85B | 12.13B | 12.63B | 12.12B |
| Current Liabilities | - | - | 2.67B | - | 2.51B | 2.92B | 2.72B | 2.39B |
| Long Term Debt | - | - | 0 | - | 8.90B | 8.75B | 8.86B | 8.63B |
| Total Debt | - | - | - | - | 8.91B | 8.76B | 8.88B | 8.64B |
| Total Equity | 6.35B | 7.04B | 5.49B | - | -892.00M | -70.00M | 472.00M | 752.00M |
| Shares Outstanding | - | - | - | - | 254.37M | 255.63M | 257.80M | 260.32M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | 858.00M | 799.00M | 939.00M | 700.00M |
| Investing Cash Flow | - | - | - | -420.00M | -260.00M | -513.00M | -390.00M |
| Financing Cash Flow | - | - | - | -433.00M | -569.00M | -368.00M | -561.00M |
| Capital Expenditure | -92.00M | -255.00M | - | -427.00M | -261.00M | -351.00M | -316.00M |
| Free Cash Flow | - | - | - | 431.00M | 538.00M | 588.00M | 384.00M |
| Net Change in Cash | - | - | - | 5.00M | -30.00M | 58.00M | -251.00M |
| Dividends Paid | 0 | 0 | 145.00M | 290.00M | 294.00M | 297.00M | 88.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | 62.8% | 59.8% | 58.0% | 53.3% |
| Operating Margin % | - | - | - | 27.6% | 21.2% | 23.2% | 19.7% |
| Net Margin % | 41.4% | 33.1% | - | 14.9% | 16.3% | 13.5% | 3.0% |
| ROE % | 45.7% | 39.4% | - | -102.8% | -1,461.4% | 183.1% | 24.9% |
| ROCE % | - | - | - | 20.2% | 14.5% | 14.3% | 11.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for OGN
OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOdjVsdERaQTFJcDJDTDBaaTZhRmN5dTNwbWx4NUNrU2pzQUdYR0d1eW9ST1d2WjJCQ3VfMERyRDdlMUpfTm96TGczMEdYR21sOTNCX2RIQTFkbzc1MGc0ell1VEszaFNZR01LY1ZIT0I3R0NHRkRGai00SjdxeG9jeE1oUkx0LUYxeHN5Zm…
Organon (OGN) Stock Stalls As Margin Compression Keeps Value Debate Alive - webull.com
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE81OGJCZ2lZa0RJcXpGTWE4dEVXRWFBS0doQTlMU01RQmxPTXRpOGUwcFMyUFl3VURGSUE5SGp6VmdrWWVvLVVRS181QUN1dGE5Y3R6X1BOaUw?oc=5" target="_blank">Organon (OGN) Stock Stalls As Margin Compression…
Organon (OGN) Stock Stalls As Margin Compression Keeps Value Debate Alive - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxQc2RKa0RPNWpPdUZES1pQQWhlckxEVmFQcmZfWjRHZHJORGt2SnBPX21WaG9ZMXFSTnhJdGZjNC1fbjhwVHRab3QtUTFfOVRpT1g4ZjRUdUJhQkl4eWtWenotQ1BydWZraXdjT3FEckhFN0Ryazg1WXVJenJRWjBRNU5PczBubW92TzRCaT…
Organon & Co. (OGN) Stock Analysis: Valuation Insights and Investor Outlook Amidst Market Challenges - DirectorsTalk Interviews
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxPbzlRNHZyS2lMeGg1ckhueUVMb0xDRTJ2VEhFWkt1NFdUWnpMSEdHeWFuTi1ReGR2Z0JSQ19LRmxzRmIxVEF1Vm54N3JUTlplOFFtaFoxOUJTVUo4dEtYb0R2QjBOU1BnazMyMVQ5bXFyLXdYczVqVlU3dW1qTF8xTVYyYlFyVl9ndE0zbS…
Organon (OGN) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPSDVoQVVrMG9Gek1NSHdaZC1fRC1xRlhGWlJTNU9ZeWJzckV1Yi1OQmlBb081c0ZHM1RZVWE0ZEVMNmgwZmo0RHlFSGhINmVHeFpkVUo2ZTRxNDNYaEF5LUVoeTZkVFVPcXprNGl4bzdpZ1hYNDJMdnZmX2dmU3VhZnpzNGdMSjJQVkZMTW…
Why Did NOK, OGN, XE Stocks Hit 52-Week Highs Today? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxNalFNYUd4b0Vnc0J6eERKVWJmRTN4ZC05TFRYTTRCQ1FVMjdQdng5SVA1NUoxd2JFSEZSYnhpTVFJTDBSRUZibWpYSmZfS3MyZU9CWWJ4c2daQ1ZmVl9SWXZkLXh6dzBWSzg4Z1BXTHYxT0FBSmpIRHMzeUhobjh0RmRFOW9JZ3lTMnFHND…
OGN — Frequently Asked Questions
What is the current share price of OGN?
As of 2026-08-05 17:25 PDT, OGN trades at $13.57 on NASDAQ/NYSE. Its 52-week range is $5.69 to $13.57.
What is the market capitalisation of OGN?
OGN has a market capitalisation of $3.53B on NASDAQ/NYSE.
What is the P/E ratio of OGN?
OGN trades at a trailing price-to-earnings (P/E) ratio of 18.85. Its price-to-book (P/B) ratio is 4.70.
What is the return on equity (ROE) of OGN?
OGN has a return on equity (ROE) of 24.87%. Its return on capital employed (ROCE) is 11.70%.
Is OGN a good stock to buy?
This page provides a data-driven analysis of OGN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.